Prestige Consumer Healthcare (PBH) Change in Accured Expenses (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Change in Accured Expenses of $2.4 million for Q4 2025, down 35.5% year-over-year from $3.8 million in Q4 2024, and down 48.59% quarter-over-quarter from $4.7 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Change in Accured Expenses history runs 16 years deep, the most recent figure standing at $2.4 million for Q4 2025.
- In Q4 2025, Change in Accured Expenses fell 35.5% year-over-year to $2.4 million; the TTM figure through Dec 2025 stood at $9.0 million (up 317.72% YoY), while the FY2025 annual figure was $7.0 million, up 143.07% from the prior year.
- Change in Accured Expenses for Q4 2025 stood at $2.4 million, down from $4.7 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $18.4 million in Q2 2021, with the low at -$23.1 million in Q1 2021.
- The 5-year median for Change in Accured Expenses is $830500.0 (2022), against an average of -$283250.0.
- The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses jumped 379.42% in 2023, then tumbled 453.98% in 2024.
- Prestige Consumer Healthcare's Change in Accured Expenses stood at -$9.5 million in 2021, then surged by 84.84% to -$1.4 million in 2022, then surged by 379.42% to $4.0 million in 2023, then declined by 6.37% to $3.8 million in 2024, then slumped by 35.5% to $2.4 million in 2025.
- Business Quant data shows PBH's Change in Accured Expenses at $2.4 million in Q4 2025, $4.7 million in Q3 2025, and -$813000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.44 Mn |
| Dec 31, 2025 | 2.44 Mn |
| Sep 30, 2025 | 4.74 Mn |
| Sep 30, 2025 | 4.74 Mn |
| Jun 30, 2025 | -813,000.00 |
| Jun 30, 2025 | -813,000.00 |
| Mar 31, 2025 | 2.63 Mn |
| Mar 31, 2025 | 2.63 Mn |
| Dec 31, 2024 | 3.78 Mn |
| Dec 31, 2024 | 3.78 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | -2.06 Mn |
| Jun 30, 2024 | -2.06 Mn |
| Mar 31, 2024 | -8.49 Mn |
| Mar 31, 2024 | -8.49 Mn |
| Dec 31, 2023 | 4.03 Mn |
| Dec 31, 2023 | 4.03 Mn |
| Sep 30, 2023 | -3.25 Mn |
| Sep 30, 2023 | -3.25 Mn |